Bowman, Thomas
Pergolini, Andrea
Carrozza, Maria Chiara
Lencioni, Tiziana
Marzegan, Alberto
Meloni, Mario
Vitiello, Nicola
Crea, Simona
Cattaneo, Davide
Funding for this research was provided by:
CYBERLEGs Plus Plus project within the H2020 framework (731931)
Ministero della Salute (Ricerca corrente 2021)
Article History
Received: 20 January 2023
Accepted: 11 June 2024
First Online: 26 June 2024
Declarations
:
: The study protocol was registered (DGDMF.VI/P/I.5.i.m.2/2019/1297) and approved by the General Directorate of Medical Devices and Pharmaceutical Service of the Italian Ministry of Health and by the ethics committee of the Lombardy region (Milan, Italy).
: Written informed consent for publication has been given by all subjects.
: MCC, NV, and SC have interests in IUVO S.r.l (Pontedera, Pisa, Italy). Part of the IP covering the technology presented in this paper has been exclusively licensed to IUVO for commercial exploitation.